Format
Sort by
Items per page

Send to

Choose Destination

Best matches for cx3cr1 multiple sclerosis:

CX3CR1 in multiple sclerosis. Rivest S et al. Oncotarget. (2015)

Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis. Friess J et al. Sci Rep. (2017)

Microglia in Health and Disease. Ransohoff RM et al. Cold Spring Harb Perspect Biol. (2015)

Search results

Items: 1 to 20 of 40

1.

Role of the Fractalkine Receptor in CNS Autoimmune Inflammation: New Approach Utilizing a Mouse Model Expressing the Human CX3CR1I249/M280 Variant.

Cardona SM, Kim SV, Church KA, Torres VO, Cleary IA, Mendiola AS, Saville SP, Watowich SS, Parker-Thornburg J, Soto-Ospina A, Araque P, Ransohoff RM, Cardona AE.

Front Cell Neurosci. 2018 Oct 17;12:365. doi: 10.3389/fncel.2018.00365. eCollection 2018.

2.

Laquinimod attenuates inflammation by modulating macrophage functions in traumatic brain injury mouse model.

Katsumoto A, Miranda AS, Butovsky O, Teixeira AL, Ransohoff RM, Lamb BT.

J Neuroinflammation. 2018 Jan 30;15(1):26. doi: 10.1186/s12974-018-1075-y.

3.

Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression.

Murdock BJ, Zhou T, Kashlan SR, Little RJ, Goutman SA, Feldman EL.

JAMA Neurol. 2017 Dec 1;74(12):1446-1454. doi: 10.1001/jamaneurol.2017.2255.

4.

E6130, a Novel CX3C Chemokine Receptor 1 (CX3CR1) Modulator, Attenuates Mucosal Inflammation and Reduces CX3CR1+ Leukocyte Trafficking in Mice with Colitis.

Wakita H, Yanagawa T, Kuboi Y, Imai T.

Mol Pharmacol. 2017 Nov;92(5):502-509. doi: 10.1124/mol.117.108381. Epub 2017 Aug 25.

5.

Acetylcholine-producing NK cells attenuate CNS inflammation via modulation of infiltrating monocytes/macrophages.

Jiang W, Li D, Han R, Zhang C, Jin WN, Wood K, Liu Q, Shi FD, Hao J.

Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):E6202-E6211. doi: 10.1073/pnas.1705491114. Epub 2017 Jul 10.

6.

Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis.

Friess J, Hecker M, Roch L, Koczan D, Fitzner B, Angerer IC, Schröder I, Flechtner K, Thiesen HJ, Winkelmann A, Zettl UK.

Sci Rep. 2017 Feb 3;7:42087. doi: 10.1038/srep42087.

7.

Opposing Functions of Microglial and Macrophagic TNFR2 in the Pathogenesis of Experimental Autoimmune Encephalomyelitis.

Gao H, Danzi MC, Choi CS, Taherian M, Dalby-Hansen C, Ellman DG, Madsen PM, Bixby JL, Lemmon VP, Lambertsen KL, Brambilla R.

Cell Rep. 2017 Jan 3;18(1):198-212. doi: 10.1016/j.celrep.2016.11.083.

8.

Monocyte behaviour and tissue transglutaminase expression during experimental autoimmune encephalomyelitis in transgenic CX3CR1gfp/gfp mice.

Chrobok NL, Jaouen A, Fenrich KK, Bol JG, Wilhelmus MM, Drukarch B, Debarbieux F, van Dam AM.

Amino Acids. 2017 Mar;49(3):643-658. doi: 10.1007/s00726-016-2359-0. Epub 2016 Nov 9.

9.

Dysregulation of Chemokine/Chemokine Receptor Axes and NK Cell Tissue Localization during Diseases.

Bernardini G, Antonangeli F, Bonanni V, Santoni A.

Front Immunol. 2016 Oct 6;7:402. eCollection 2016. Review.

10.

LRP1 expression in microglia is protective during CNS autoimmunity.

Chuang TY, Guo Y, Seki SM, Rosen AM, Johanson DM, Mandell JW, Lucchinetti CF, Gaultier A.

Acta Neuropathol Commun. 2016 Jul 11;4(1):68. doi: 10.1186/s40478-016-0343-2.

11.

Synaptic Failure: Focus in an Integrative View of ALS.

Casas C, Manzano R, Vaz R, Osta R, Brites D.

Brain Plast. 2016 Jun 29;1(2):159-175. doi: 10.3233/BPL-140001. Review.

12.

Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease.

Thome AD, Standaert DG, Harms AS.

PLoS One. 2015 Oct 15;10(10):e0140566. doi: 10.1371/journal.pone.0140566. eCollection 2015.

13.

Microglia in Health and Disease.

Ransohoff RM, El Khoury J.

Cold Spring Harb Perspect Biol. 2015 Sep 9;8(1):a020560. doi: 10.1101/cshperspect.a020560. Review.

14.

Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation.

Ryu JK, Petersen MA, Murray SG, Baeten KM, Meyer-Franke A, Chan JP, Vagena E, Bedard C, Machado MR, Rios Coronado PE, Prod'homme T, Charo IF, Lassmann H, Degen JL, Zamvil SS, Akassoglou K.

Nat Commun. 2015 Sep 10;6:8164. doi: 10.1038/ncomms9164.

15.

CX3CR1 in multiple sclerosis.

Rivest S.

Oncotarget. 2015 Aug 21;6(24):19946-7. No abstract available.

16.

Cuprizone-induced demyelination and demyelination-associated inflammation result in different proton magnetic resonance metabolite spectra.

Praet J, Orije J, Kara F, Guglielmetti C, Santermans E, Daans J, Hens N, Verhoye M, Berneman Z, Ponsaerts P, Van der Linden A.

NMR Biomed. 2015 Apr;28(4):505-13. doi: 10.1002/nbm.3277.

17.

Inefficient clearance of myelin debris by microglia impairs remyelinating processes.

Lampron A, Larochelle A, Laflamme N, Préfontaine P, Plante MM, Sánchez MG, Yong VW, Stys PK, Tremblay MÈ, Rivest S.

J Exp Med. 2015 Apr 6;212(4):481-95. doi: 10.1084/jem.20141656. Epub 2015 Mar 16.

18.

The role of fractalkine (CX3CL1) in regulation of CD4(+) cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosis.

Blauth K, Zhang X, Chopra M, Rogan S, Markovic-Plese S.

Clin Immunol. 2015 Apr;157(2):121-32. doi: 10.1016/j.clim.2015.01.001. Epub 2015 Jan 14.

PMID:
25596452
19.

Differential roles of microglia and monocytes in the inflamed central nervous system.

Yamasaki R, Lu H, Butovsky O, Ohno N, Rietsch AM, Cialic R, Wu PM, Doykan CE, Lin J, Cotleur AC, Kidd G, Zorlu MM, Sun N, Hu W, Liu L, Lee JC, Taylor SE, Uehlein L, Dixon D, Gu J, Floruta CM, Zhu M, Charo IF, Weiner HL, Ransohoff RM.

J Exp Med. 2014 Jul 28;211(8):1533-49. doi: 10.1084/jem.20132477. Epub 2014 Jul 7.

20.

Apolipoprotein E mediation of neuro-inflammation in a murine model of multiple sclerosis.

Shin S, Walz KA, Archambault AS, Sim J, Bollman BP, Koenigsknecht-Talboo J, Cross AH, Holtzman DM, Wu GF.

J Neuroimmunol. 2014 Jun 15;271(1-2):8-17. doi: 10.1016/j.jneuroim.2014.03.010. Epub 2014 Mar 29.

Supplemental Content

Loading ...
Support Center